Skip to main content

Posters

You are here

Dataroom

Preference and acceptance of HPV self-sampling: Gaining insights on urine as a sample type (EUROGIN 2021)

Posted on 10/06/2021

Eurogin - Laeremans et al., 2021.

Feedback from a colposcopy referral population on the use of Colli-Pee for HPV-based cervical cancer screening (CASUS) (EUROGIN 2021)

Posted on 10/06/2021

Eurogin - Laeremans et al., 2021.

Post-collection stability of human papillomavirus DNA in first-void urine (EUROGIN 2021)

Posted on 10/06/2021

Eurogin - Laeremans et al., 2021.

Disclaimer

Effective December 8th, 2024, DNA Genotek™ will be the Legal Manufacturer of the Colli-Pee™ product family.
This transfer of all Colli-Pee™ devices to DNA Genotek™ as the new Legal Manufacturer will have no impact to product performance or how you place orders for the product. Please note that this change will have no impact on the Colli-Pee™ device design or specifications and there is no change to Colli-Pee™ device fit, form or function.

The Legal Manufacturing change will only result in changes to Colli-Pee™ device labelling to list DNA Genotek™ as the Legal Manufacturer. For a limited period of time, you may receive product with labelling indicating either Novosanis™ or DNA Genotek™ as the Legal Manufacturer on the product label. Both Novosanis™ and DNA Genotek™ are subsidiaries of OraSure Technologies, Inc.

2024 © Novosanis, a subsidiary of OraSure Technologies, Inc., all rights reserved.